Japan Biotechnology Reagents & Kits Market Size & Outlook
The biotechnology reagents & kits market in Japan is expected to reach a projected revenue of US$ 58.7 billion by 2028. A compound annual growth rate of 16.4% is expected of Japan biotechnology reagents & kits market from 2021 to 2028.
Thermo Fisher Scientific Inc, Qiagen NV, New England Biolabs, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, LGC Group, Toyobo Co Ltd
Other key industry trends
In terms of revenue, Japan accounted for 5.2% of the global biotechnology reagents & kits market in 2020.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
In Asia Pacific, China biotechnology reagents & kits market is projected to lead the regional market in terms of revenue in 2028.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 106.0 billion by 2028.
Japan's biotechnology reagent and kits market is marked by numerous initiatives adopted by key players, to reinforce their global presence and strengthen their product offerings.
In May 2020, Takara Bio Inc. launched a reagent for PCR testing ofSARS-CoV-2, using saliva specimen. The reagent is designed to reduce medical researcher's risk of infection and increase the number of PCR tests conducted in Japan.
On other hand, in October 2019, Alto Bio Reagent Ltd. entered into a distribution agreement with a Japanese partner Veritas Corporation. It was a part of a big enterprise Ireland trade mission to Japan. Veritas is a partner to around 70 suppliers in the reagent, diagnostics, and life sciences sectors.
Japan Biotechnology Reagents & Kits Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biotechnology Reagents & Kits Market Outlook will help companies and investors design strategic landscapes.
Detection Kits was the largest segment with a revenue share of 22.86% in 2020.
Horizon Databook has segmented the Japan biotechnology reagents & kits market based on purification kits, amplification kits, detection kits, isolation kits covering the revenue growth of each sub-segment from 2018 to 2028.
Japan's biotechnology reagent and kits market is marked by numerous initiatives adopted by key players, to reinforce their global presence and strengthen their product offerings.
In May 2020, Takara Bio Inc. launched a reagent for PCR testing ofSARS-CoV-2, using saliva specimen. The reagent is designed to reduce medical researcher's risk of infection and increase the number of PCR tests conducted in Japan.
On other hand, in October 2019, Alto Bio Reagent Ltd. entered into a distribution agreement with a Japanese partner Veritas Corporation. It was a part of a big enterprise Ireland trade mission to Japan. Veritas is a partner to around 70 suppliers in the reagent, diagnostics, and life sciences sectors.
Japan Biotechnology Reagents & Kits Market Kit Type Outlook (Revenue, USD BIllion , 2018-2028)
Purification Kits
Amplification Kits
Detection Kits
Isolation Kits
Others
Japan Biotechnology Reagents & Kits Market Technology Outlook (Revenue, USD BIllion , 2018-2028)
LAMP technology
PCR
Cell Culture
Sequencing
Chromatography
Electrophoresis
Flow Cytometry
Other Technologies
Japan Biotechnology Reagents & Kits Market Tested Parameters Outlook (Revenue, USD BIllion , 2018-2028)
DNA
RNA
Enzymes
Proteins
Others
Japan Biotechnology Reagents & Kits Market Micro-Organisms Outlook (Revenue, USD BIllion , 2018-2028)
Bacteria
Virus
Fungi
Parasites
Japan Biotechnology Reagents & Kits Market Purpose Outlook (Revenue, USD BIllion , 2018-2028)
On-Site
Laboratory
Japan Biotechnology Reagents & Kits Market End-use Outlook (Revenue, USD BIllion , 2018-2028)
Healthcare
Food & Agriculture
Natural reseources & Environment
Industrial Processing
Others
Reasons to subscribe to Biotechnology Reagents & Kits Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biotechnology Reagents & Kits Market Outlook databook
Our clientele includes a mix of Biotechnology Reagents & Kits Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Biotechnology Reagents & Kits Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Biotechnology Reagents & Kits Market Outlook from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Japan Biotechnology Reagents Kits Market, 2018-2028 (US$B)